Pharma/BioTech Archives - British Herald
November 27, 2021

Pharma/BioTech

Pharma/BioTech

Point of Care Diagnostics Market Size to Reach USD 35370 Million by 2027 at CAGR 5.7% – Valuates Reports

BANGALORE – The Point of Care Diagnostics Market is Segmented by Type (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing, Cholesterol Testing, Others), End User (Clinics, Hospitals, Assisted Living Healthcare
Pharma/BioTech

Female-Owned Biotech Startup Tiamat Sciences Raises $3 Million to Manufacture Plant-Based Biomolecules

DURHAM – Biotechnology startup Tiamat Sciences today announced its $3 million seed financing round led by Silicon Valley venture capital firm True Ventures with participation from Social Impact Capital and Cantos. Tiamat Sciences manufactures animal-free proteins using a proprietary plant molecular farming platform. By replacing costly bioreactors with plants, the
Pharma/BioTech

The Lancet Infectious Diseases: First real-world study reports effectiveness of BBV152 against symptomatic COVID-19 in India

Study includes more than 2,700 healthcare workers in Delhi, India, who were symptomatic and underwent RT-PCR testing for COVID-19. Findings suggest 50% vaccine effectiveness against symptomatic COVID-19 after two doses of BBV152. This vaccine effectiveness is lower than the vaccine efficacy suggested by Bharat Biotech’s phase 3 randomised control trial results. The authors
Pharma/BioTech

FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics

BOSTON – Datar Cancer Genetics Inc, a leading cancer research company focussed on early detection of cancers today announced that the US Food and Drug Administration (FDA) has granted ‘Breakthrough Device Designation’ for its ‘TriNetra™‘ blood test to detect early-stage Breast Cancer. The Breakthrough Designation is granted by the FDA for
Pharma/BioTech

Global Pain Management Devices Market (2021 to 2026) – Use of Pain Medications as the First Line of Treatment for Pain Management Presents Opportunities

DUBLIN – The “Global Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) – Forecasts to 2026” report has been added to ResearchAndMarkets.com’s offering. The global
Pharma/BioTech

DNAtrix Announces Oral Presentation of Positive Overall Survival Data with DNX-2401 in DIPG at the Society for Neuro-oncology (SNO) Annual Meeting

SAN DIEGO – DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, today announced that data from the Phase 1 study of DNX-2401 in diffuse intrinsic pontine glioma (DIPG) was presented in an oral presentation at the 26th Annual Meeting and Education Day of the Society for Neuro-oncology (SNO), which was held from November 18-21, 2021 in Boston,
Pharma/BioTech

USD 12.75 Bn growth in Adhesive Market | Increasing Demand for Adhesives in Medical Industry to Boost Growth | Technavio

NEW YORK, Nov. 18, 2021 /PRNewswire/ — The global adhesive market size is expected to increase by USD 12.75 bn during 2020-2025, progressing at a CAGR of over 4% during the forecast period, according to Technavio. The report offers an up-to-date analysis of the growth variance and the Y-O-Y growth rate. Purchase our full report on the adhesive